We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Novel Biomaterial Platform Opens Up New Possibilities for Implants and Devices

By HospiMedica International staff writers
Posted on 26 Jul 2024
Print article
Image: Fixation screws for ligament to bone repair (Photo courtesy of 4D Medicine)
Image: Fixation screws for ligament to bone repair (Photo courtesy of 4D Medicine)

Resorbable biomaterials, crucial for implantable medical devices, have seen little innovation over decades. Materials like Polylactic Acid (PLA), Polycaprolactone (PCL), and Poly Lactic-co-Glycolic Acid (PLGA), despite their widespread use, have often delivered less-than-ideal clinical results, with several significant drawbacks identified. Now, a patent-protected resorbable photocurable resin based on unique polycarbonate urethane chemistry could free resorbable medical device design from historic constraints and overcome the clinical performance issues of currently available materials.

4D Medicine Limited (Nottingham, UK) has developed 4Degra, a resorbable biomaterial now being utilized to create a variety of implants, such as orthopedic devices and soft tissue scaffolds. This material supports patients in their recovery from surgeries and injuries, offering a broader scope for the manufacture of 3D-printed implants and surgical devices. Early testing indicates that as the healing process advances, 4Degra slowly erodes and is naturally absorbed by the body, allowing for the regeneration of natural tissues.

4Degra offers significant improvements over traditional resorbable materials used in implants. Unlike some materials that decompose quickly and produce acidic by-products that can lead to pain, inflammation, and cyst formation, 4Degra degrades gradually from its surface without releasing these harmful substances. Additionally, 4Degra's versatility in 3D printing allows for the creation of complex shapes and is available in both soft and hard formulations, making it suitable for a diverse range of products from flexible films and membranes to rigid items like plates, pins, and bone scaffolds. 4D Medicine is now working towards completing pre-clinical testing of its first product range and obtaining FDA clearance to enter the U.S. market.

Related Links:
4D Medicine Limited

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Hemodialysis Treatment System
Dialog+
New
Treatment Chair
2 Section Bariatric Plinth

Print article

Channels

Critical Care

view channel
Image: Artificial intelligence-derived intracranial pressure monitors vital information noninvasively (Photo courtesy of Icahn Mount Sinai)

AI-Driven Tool to Revolutionize Brain Pressure Monitoring in Intensive Care Patients

Intracranial hypertension, characterized by increased pressure within the brain, can lead to severe consequences such as strokes and hemorrhages. Traditionally, monitoring this condition requires invasive... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
The Atellica VTLi Patient-side Immunoassay Analyzer, a high-sensitivity troponin I test at the bedside, delivers accurate results in just 8 minutes (Photo courtesy of Siemens Healthineers)

New 8-Minute Blood Test to Diagnose or Rule Out Heart Attack Shortens ED Stay

Emergency department overcrowding is a significant global issue that leads to increased mortality and morbidity, with chest pain being one of the most common reasons for hospital admissions.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.